glp-1 receptor agonists Comparing Ozempic, Wegovy and Other Drugs A schematic overview of GLP-1
Description
They act on receptors in the brain to influence and decrease eating behavior
However, muscle mass does not appear to recover when the drug is stopped and is of potential concern especially for older patients though its impact on overall health is unclear (1)
2019;3(12):nzz120
Therefore, the pharmacist must be prepared to explain the appropriate and safe use of GLP-1 receptor agonist therapy for patients being prescribed this class to meet target A1C goals
On growth and development, the review concludes there are no consistent impacts documented so far [1]
